. home.aspx

NEWS

home.aspx
   


Has the Indian pharmaceutical sector become a soft target?

April 03, 2017 / DG Shah
SHARESHARESHARE

The last one year has witnessed more than 400 Indian and foreign pharmaceutical companies going to the courts to resolve their grievances. Almost of all of them relate to implementation of the pricing policy and haphazard banning of fixed dose combinations (FDCs).